4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-24-002021
CFO and CBO sold 6,307 shares at $7.75 ($48,900)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Molly CFO and CBO | 2024-01-19 | Sale | −6,307 | $7.75 | $48,900 | 98,698 | D |
| Derivatives | |||||||
| Henderson Molly CFO and CBO | 2024-01-18 | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | D | ||
| Open-market sales · 6,307 sh · avg $7.75 · $48,900 | |||||||
Loading xslF345X05/doc4.xml…